SCHEDULE 13G/A: Millennium Management Divests Entire Stake in KALA BIO, Inc., Filing Amended Beneficial Ownership Report

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed an amended Schedule 13G indicating they no longer beneficially own any shares of KALA BIO, Inc. common stock as of March 31, 2025.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, collectively the Reporting Persons, have filed an Amendment No. 1 to their Schedule 13G.
• The filing indicates that as of March 31, 2025, the Reporting Persons beneficially own 0.00 shares of KALA BIO, Inc. common stock.
• This represents 0.0% of the outstanding class of KALA BIO, Inc. common stock.
• The previous filing would have indicated ownership above the 5% threshold, which necessitated the initial Schedule 13G.
• The purpose of the acquisition of securities was not for changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of a change in beneficial ownership to zero, which is a neutral event in terms of the company's operational performance. While an investor's exit can be viewed negatively, this is a passive filing and not an active 'sell' announcement.

Negatives

• The divestment of an entire stake by an institutional investor like Millennium Management could be perceived as a negative signal by some market participants, although this filing is a disclosure of a past event rather than an announcement of intent to sell.

Risks

• The document itself does not detail specific risks related to KALA BIO, Inc.'s operations or financial health. It is solely a disclosure of beneficial ownership change.

Future Outlook

The document does not contain any forward-looking statements or guidance from KALA BIO, Inc. or the reporting persons regarding KALA BIO's future performance.

Management Comments

• Gil Raviv, Global General Counsel for Millennium Management LLC and Millennium Group Management LLC, signed the filing.
• Israel A. Englander also signed the filing.

Industry Context

This filing is a routine disclosure of a change in passive institutional ownership, common in the biotech sector where investment firms frequently adjust their positions based on market conditions and company developments. It does not provide specific insights into broader industry trends beyond the general activity of institutional investors.

Stakeholder Impact

• Shareholders of KALA BIO, Inc. may note the complete divestment of shares by Millennium Management, which could influence sentiment, though the actual selling would have occurred prior to this disclosure.

Key Dates

Keywords

KALA BIO Inc., Millennium Management LLC, Millennium Group Management LLC, Israel A. Englander, Schedule 13G/A, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Divestment